Norvegia -
norvegese -
Statens legemiddelverk
furosemid 500 mg
orion corporation orion pharma - furosemid - tablett - 500 mg
Norvegia -
norvegese -
Statens legemiddelverk
lescol depot 80 mg
ethyx pharmaceuticals sas - fluvastatinnatrium - depottablett - 80 mg
Norvegia -
norvegese -
Statens legemiddelverk
lasix retard 30 mg
sanofi-aventis norge (3) - furosemid - depotkapsel, hard - 30 mg
Norvegia -
norvegese -
Statens legemiddelverk
lasix retard 60 mg
sanofi-aventis norge (3) - furosemid - depotkapsel, hard - 60 mg
Norvegia -
norvegese -
Statens legemiddelverk
nemona 49.5 % w/w
nouryon pulp and performance chemicals ab - hydrogenperoksid - konsentrat til behandlingsoppløsning til fisk - 49.5 % w/w
Unione Europea -
norvegese -
EMA (European Medicines Agency)
tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfom, mantelcelle - antineoplastiske midler - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).
Norvegia -
norvegese -
myHealthbox
hussar plus od
bayer ag - jodsulfuron 50 g/l; mesosulfuron 7,5 g/l